Articles tagged with Tissue Engineering
Researchers on the International Space Station have developed human liver tissues with enhanced functionality in microgravity, paving the way for novel stem cell-derived liver tissues and alternative to traditional liver transplants. The team also created a bioreactor system for stable supercooling preservation of tissues.
Concordia researchers develop a novel method of 3D printing using acoustic holograms, capable of creating complex objects quickly and at once. This technique, called holographic direct sound printing (HDSP), stores information of multiple images in a single hologram, allowing for the creation of multiple objects simultaneously.
Researchers developed a tri-culture heart-on-a-chip model of cardiomyocytes, fibroblasts, and endothelial cells to mimic in vivo cardiac behavior. The study successfully replicated endothelial cell morphology and functionality, as well as cardiac function with increased contractility.
Dr. Josephine Wu's project, OPTO-BIOPRINTING, aims to develop a novel platform for spatiotemporally guided tissue engineering using cellular self-assembly and light triggering. The goal is to create living organ replacements that can perform as well as native equivalents.
Researchers led by Prof. Michael Brand successfully regenerated photoreceptors in zebrafish, demonstrating they regain their normal function and allowing the fish to recover complete vision. This breakthrough could potentially revolutionize treatment of diseases like retinitis pigmentosa or macular degeneration.
A new implant has been developed to encourage nerve cell repair after spinal cord injury. The implant uses electrical signals and a 3D-printed scaffold to bridge the gap and direct axons to grow back in the correct formation, promoting healing and recovery.
Researchers at Technical University of Denmark developed a new biopolymer, PAMA, derived from bacteria to heal tissue. The PAMA bactogel shows significant muscle regeneration properties and nearly 100% mechanical recovery in rats.
Scientists have developed a new way to 3D print materials that are strong enough to support human tissue and vary in shape and size. The breakthrough, known as CLEAR, helps pave the way toward a new generation of biomaterials for personalized implants and tissues.
The new journal Cell Organoid aims to push the boundaries of knowledge in organoid research, fostering innovation and collaboration across disciplines. The journal seeks to advance personalized medicine and therapeutic interventions by addressing ethical, technical, and standardization challenges.
Terasaki Institute scientists have created a novel bioink derived from egg whites, offering abundant proteins and excellent biocompatibility. This breakthrough technology has the potential to create more accurate tissue models for drug testing and develop functional tissue replacements for regenerative medicine applications.
Researchers developed core-shell microfibrous scaffolds that excel in rotator cuff repair, restoring natural morphology and mechanical properties. The acellular, in situ tissue engineering technology harnesses stem cell regenerative abilities to provide robust biological regeneration without cell seeding.
A UVA research team has developed biomaterials with controlled mechanical properties matching those of various human tissues, representing a significant leap in bioprinting technologies. Their unique digital assembly of spherical particles (DASP) technique can deposit particles of biomaterial in a supporting matrix to build 3D structur...
Professors Philip LeDuc and Burak Ozdoganlar have developed a novel 3D ice printing technique that enables the creation of micro-scale structures with tailored geometries. Their method uses water as an ink substitute, allowing for the deposition of precise internal voids and channels.
Researchers have developed a biodegradable scaffold to facilitate bladder tissue growth, reducing complications associated with traditional augmentation procedures. An implantable sensor also enhances patient monitoring, paving the way for improved bladder surgery outcomes.
Researchers at Duke University created an ultrathin silk membrane that helps cells grow into functional tissues used for research, enabling the development of kidney disease models. The new membrane improves communication and growth between cells, mimicking natural human organ structures.
Researchers created a prototype of 'living bioelectronics', combining bacteria, sensors, and gel to integrate with living tissue. The device reduced inflammation and improved psoriasis-like symptoms in mice, offering potential for treating various skin conditions and injuries.
The DRIVE-RM consortium, led by UMC Utrecht, aims to develop smart materials that assist the body in healing and regenerate tissues and organs using regenerative medicine. The project focuses on treating chronic diseases such as heart failure, kidney failure, and worn joints.
A team of scientists at the University of Ottawa has developed a novel peptide-based hydrogel that can be used for on-the-spot repair to damaged organs and tissues. The material shows great potential for closing skin wounds, delivering therapeutics to damaged heart muscle, and reshaping and healing injured corneas.
Scientists have developed mini-colon tissues that can simulate the complex process of tumorigenesis outside the body with high fidelity. These miniature organs mimic the physical structure and cellular diversity of colon tissue, allowing researchers to study colorectal cancer development and test potential therapies.
Researchers from Technion Faculty of Biomedical Engineering developed a breakthrough method for bio-printing live cells and tissues using external sound wave irradiation. The innovation enables precise localized delivery of biocompatible materials for various biomedical applications, reducing invasive surgeries and associated risks.
Researchers will develop 'live' joints with biocompatible bone and cartilage grown from human cells, aiming to scale up the technology for commercial use. The project, valued at $47.7M, targets 40 patients within five years with knee replacements.
Scientists have developed a novel maleic acid-treated bacterial cellulose gel that significantly improves bone repair outcomes. The gel's enhanced biocompatibility and osteogenic gene expression promote cell proliferation and differentiation, paving the way for potential applications in tissue engineering.
A clinical trial with PeriCord, a new tissue engineering product derived from umbilical cord and pericardium stem cells, confirms its feasibility in repairing damaged heart tissues after a heart attack. The therapy has demonstrated excellent biocompatibility and anti-inflammatory properties.
Researchers created a hydrogel that kills bacteria naturally, promotes cell growth and heals wounds more effectively than traditional gels. The gel is infused with amino acid polylysine and platelet-rich blood plasma to create properties well-suited for wound care.
Researchers develop PFBN to address mechanical challenges of intertrochanteric femur fractures, significantly reducing complications and improving patient outcomes. The study demonstrates the PFBN's ability to regulate local mechanical environment, promoting post-operative recovery for elderly patients.
Researchers at Weill Cornell Medicine have developed a novel method to create grafts that accurately replicate the human ear's anatomy and biomechanical properties. The new technique uses 3D printing and tissue engineering to produce cartilage-containing structures that mimic the ear's shape, flexibility, and elasticity.
Recent advances in tissue engineering have shown that mesenchymal stem cells (MSCs) and growth factors (GFs) can significantly enhance the regeneration of rotator cuff tendon-to-bone insertion. However, a comprehensive overview is lacking to translate these findings into clinical practice.
Scientists create a hydrogel system that can remember its shape, allowing them to control cell adhesion behavior. The elastic modulus of the hydrogel is adjusted by compressing it into different thicknesses at high temperatures.
A new study highlights the contributions of 50 top scientists from elite universities to transforming medicine through cutting-edge biomedical engineering advances. Five primary medical challenges are identified, including precision engineering for personalized care and tissue engineering for human health.
Researchers identify five grand challenges in biomedical engineering to address social needs, existing gaps, and technological limitations. The Convergence Revolution and Fourth Industrial Revolution are expected to shape the future of medicine, emphasizing interdisciplinary collaborations and next-generation training.
Researchers create a simple method to instantly bond layers made of the same or different types of hydrogels using a thin film of chitosan. The new approach has potential to broadly advance new biomaterials solutions for multiple unmet clinical needs, including regenerative medicine and surgical care.
Researchers at McGill University discovered a new mechanism for the attachment of avian eggshell membranes to their shells. This finding has significant implications for tissue engineering and biomaterial grafts, as well as reducing losses in the commercial egg and poultry industry.
University of Melbourne researchers have received a $35 million grant to develop a world-first tissue engineered cornea to treat corneal blindness. The technology has the potential to provide corneal tissue to surgeons worldwide, including countries with limited eye banks.
Researchers introduce trehalose into hydrogels to form hydrogen bond interactions, improving dehydration resistance, lubrication performance, mechanical properties, and manufacturing accuracy. This discovery proposes a new design principle for high-precision manufacturing of hydrogel materials.
The University of Rochester is establishing a new NIH-funded center focused on developing FDA-qualified drug development tools related to barrier functions in disease. Researchers will create microphysiological systems with ultrathin membranes of human cells, aiming to reduce animal trials and improve drug efficacy.
A team of engineers has developed a novel printing method called deep-penetrating acoustic volumetric printing (DVAP) that uses soundwaves to solidify biologically compatible structures in deep tissues. The technique involves a specialized ink that reacts to ultrasound waves, enabling the creation of intricate structures for biomedical...
Researchers created multicellular bots from human tracheal cells that move across surfaces and promote healing of damaged neurons in a lab dish. The discovery could lead to new therapeutic tools for regeneration, healing, and disease treatment using patient-derived biobots.
Researchers at RCSI University of Medicine and Health Sciences have developed a material that can speed up bone healing while reducing the risk of infections. The implant combines antimicrobial treatment with gene therapies to repair bone and prevent infection.
Researchers have developed additively manufactured Ti-Ta-Cu alloys that exhibit improved biocompatibility and bacterial resistance, making them a promising alternative to traditional Ti6Al4V implants. The alloys were found to display remarkable synergistic effects in improving both in vivo biocompatibility and microbial resistance.
The POLINA project will develop new materials and technologies for medical applications, aiming to revolutionize bioprinting for safer, smarter and affordable medical devices. The project will create micropatterned cell surface models to help study lung diseases and design new tracheal implants.
Researchers at Rensselaer Polytechnic Institute have successfully created hair follicles in human skin tissue using 3D-bioprinting techniques. This innovation has potential applications in regenerative medicine, drug testing, and understanding the complex interactions between skin and topical products.
Researchers from Tsinghua University provide an overview of biofabrication methods for single-cell feature building blocks to reconstruct engineered living systems. The techniques aim to replicate natural tissues with precise control over microenvironment and structure, benefiting biomedicine applications.
Engineers use module assembly to develop vascularized organotypic tissues with high cell density and well-organized vasculature. This approach enables the rapid generation of functional tissue substitutes with improved efficacy in treating diseases.
Scientists at UNSW Sydney have created a new material that can mimic human tissue, fight bacteria, and heal itself. The hydrogel material is made from simple peptides and has implications for biomedical research, medicine, and manufacturing technology.
Scientists from Central South University develop a novel approach to address bacterial infection in bone transplantation by enriching H2O2 and amplifying the Fenton reaction. The technique enhances biocompatibility and safety, promising reduced transplant failures and post-operative complications.
A new method for studying cancer cells' behavior on soft and stiff tissue environments has been developed, revealing crucial survival cues for cell growth. The study challenges the long-held assumption that cells prefer stiffer surfaces, opening up new possibilities for research in cancer biology and tissue engineering.
Researchers from Osaka University have developed a bioprinting technique that enables the creation of complex soft tissue structures with high fidelity. The method uses a printing support to facilitate gelation of a bioink, resulting in cell viability and viability for up to two weeks.
Researchers at Northwestern University developed Lattice, a device that simulates human disease in multiple organs to analyze interactions and test new drugs. The technology can replicate complex disease processes, allowing scientists to study the effects of obesity on endometrial cancer, for example.
Researchers at UNIST developed a microfluidic system to process blood into artificial tissue scaffolds for vascular regeneration. Autologous blood-based implants demonstrated superior wound closure rates, increased epidermis thickness, and enhanced collagen deposition in rodent skin wounds.
The Texas Heart Institute has received a five-year, $2 million grant from the National Institutes of Health to advance organ bioengineering. The project aims to develop transplantable bioartificial hearts to combat end-stage heart failure.
Researchers successfully recreated lung cancer patient's internal environment using hydrogel and 3D bioprinting, preserving specific lung cancer subtype and genetic mutation characteristics. The study enables precise drug evaluation and personalized treatment options for lung cancer patients with underlying diseases.
A miniature human heart model, approximately half a grain of rice in size, has been developed to transform drug testing and cardiovascular research. This self-paced, multi-chambered model provides real-time measurements of essential parameters, enabling unprecedented insights into heart function and diseases.
University of Melbourne researchers developed a novel approach to 'tissue engineering' blood vessels by combining multiple materials and fabrication technologies. The method creates blood vessels with complex geometries like native blood vessels, offering a transformative solution for cardiovascular disease.
Researchers at UC San Diego report new direct evidence of atrophy and fibrosis in pelvic floor muscles of women with symptoms of pelvic organ prolapse. They also showed that an acellular injectable skeletal muscle extracellular matrix hydrogel reduces the negative impact of simulated birth injury on rat pelvic floor muscles.
Researchers at Harvard developed a fiber-infused ink that allows 3D-printed heart muscle cells to align and contract like human heart cells, enabling the creation of functional heart ventricles. The innovation can be used to build life-like heart tissues with thicker muscle walls, paving the way for regenerative therapeutics.
A University College Dublin researcher has received a European Research Council Proof of Concept grant to investigate the disruptive power of macromolecular crowding in cell culture systems. The project aims to develop novel approaches for regenerative medicine by accelerating tissue development and improving therapeutic potential.
A team from Tokyo Medical and Dental University has developed a technique to improve bone regeneration over large areas in rats, using vascular endothelial growth factor (VEGF) and Runx2. The combination of these two RNAs led to better regenerative responses in bone cells than each RNA alone.
The PULSE project combines magnetic and acoustic levitation to bioprint highly sophisticated organoids that closely mimic human organs. These in vitro heart models will provide invaluable insights into cardiac physiology and pathology, enabling the development of preventive and therapeutic solutions.
Researchers from Tokyo Medical and Dental University successfully generated functional parathyroid glands from mouse embryonic stem cells using blastocyst complementation. This breakthrough study demonstrates the potential for regenerating organs in vivo and provides a new treatment option for hypoparathyroidism.
Researchers developed bio-piezoelectric smart scaffolds for next-generation bone tissue engineering, demonstrating potential for clinical applications. The scaffolds can reconstruct desired tissue EM through non-invasive ultrasonic stimulation, promoting cell adhesion and osteogenic differentiation.